pe
pep-05312 v1 CC-BY-SA-4.0

Cancer-fighting peptide

A peptide studied in the lab for its ability to fight cancer cells; experimental, not yet an approved drug.

statuscomputed targetANTICANCER length50 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.392
avg pLDDT44.5
ranking score0.435
STRUCTURE · PEP-05312 × ANTICANCER
ranking0.435
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence50 aa
15101520253035404550
EYHLMNGANG YLTRVNGKTV YRVTKDPVSA VFGVISNCWG SAGAGFGPQH
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.4347620904445648 boltz-2
3-letter notation
Glu-Tyr-His-Leu-Met-Asn-Gly-Ala-Asn-Gly-Tyr-Leu-Thr-Arg-Val-Asn-Gly-Lys-Thr-Val-Tyr-Arg-Val-Thr-Lys-Asp-Pro-Val-Ser-Ala-Val-Phe-Gly-Val-Ile-Ser-Asn-Cys-Trp-Gly-Ser-Ala-Gly-Ala-Gly-Phe-Gly-Pro-Gln-His
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Cancer-fighting peptide (pep-05312, v1). PeptideModel. https://peptidemodel.com/card/pep-05312
@peptide{pep05312,
  sequence = {EYHLMNGANGYLTRVNGKTVYRVTKDPVSAVFGVISNCWGSAGAGFGPQH},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
references 3 papers
[1]
Garvieacin Q, a Novel Class II Bacteriocin from Lactococcus garvieae BCC 43578
Tosukhowong, A. et al. Applied and Environmental Microbiology 2012
supporting
[2]
Anticancer peptides mechanisms, simple and complex
Norouzi, P. et al. Chemico-Biological Interactions 2022
supporting
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use